Filing Details
- Accession Number:
- 0001162956-14-000007
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-12-23 16:17:16
- Reporting Period:
- 2014-12-19
- Filing Date:
- 2014-12-23
- Accepted Time:
- 2014-12-23 16:17:16
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 926617 | Vermillion Inc. | VRML | In Vitro & In Vivo Diagnostic Substances (2835) | 330595156 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1162956 | T James Lafrance | C/O Vermillion, Inc. 12117 Bee Caves Rd Bldg 3 Ste 100 Austin TX 78738 | President & Chief Exec Officer | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock, Par Value $0.001 Per Share | Acquisiton | 2014-12-19 | 16,502 | $1.44 | 94,524 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Warrants (Right to buy) | Acquisiton | 2014-12-19 | 9,901 | $0.13 | 9,901 | $2.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 9,901 | 2015-06-23 | 2017-12-23 | No | 4 | P | Direct |
Billionaire Hedge Funds
